Patents

US 10017480 B2: Compounds having a selective PDE4D inhibiting activity

Granted
2018-07-10
Filed
2015-02-10 application 15119034
Type
Utility · 12 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Compounds of formula (I), wherein Z=cyclopentyl. cyclopropylmethyl, —CH3; R′═—CH3, CHF2, X=formula (II) (III) (IV) (V) Y=—CO; —C═O(CH2), —CH(OH)—CH2, —CH2—C═O, —CH2—CH2—C═O; —CH2—CH(OH)—CH2, —CH2—CH(OCOR1)—CH2 NR2═ —N(CH2—CH2OH)2, formula (VI) (VII) (VIII) (IX) (X) (XI) R1=optionally substituted C1-C8 alkyl, optionally substituted aryl; optionally substituted aralkyl, preferably C1-C3 alkyl, more preferably CH3; and enantiomers, diastereoisomers and pharmaceutically acceptable salts thereof; these compounds have a PDE4D inhibiting activity and can be used as a medicament for treating dementia, in particular Alzheimer disease, and for improving memory.

Source: PVGPATDIS, file of 2026-04-10 (ipg180710.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Università Degli Studi Di Genova 23 patentsForeign company or organizationGenova, ITPVGPATDIS, file of 2026-04-10
COLUMBIA UNIVERSITY 26 patentsUS company or organizationNew York, NYTRUSTEES OF COLUMBIA UNIVERSITY Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and statePVGPATDIS, file of 2026-04-10
Maastricht University 7 patentsForeign company or organizationEijsden, NLPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Olga BrunoGenova, IT2PVGPATDIS, file of 2026-04-10
Chiara BrulloGenova, IT1PVGPATDIS, file of 2026-04-10
Alessia RomussiGenova, IT4PVGPATDIS, file of 2026-04-10
Ernesto FedeleGenova, IT1PVGPATDIS, file of 2026-04-10
Roberta RicciarelliGenova, IT1PVGPATDIS, file of 2026-04-10
Ottavio ArancioNew York, NY21PVGPATDIS, file of 2026-04-10
Jos PrickaertsEijsden, NL2PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D261/04PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P25/28PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2018-06-11Assignment
Assignment of assignor's interest
RICCIARELLI, ROBERTA signed 2016-09-28
BRULLO, CHIARA signed 2016-09-29
BRUNO, OLGA signed 2016-09-29
FEDELE, ERNESTO signed 2016-09-29
ROMUSSI, ALESSIA signed 2016-09-30
PRICKAERTS, JOS signed 2016-10-26
ARANCIO, OTTAVIO signed 2017-06-05
THE TRUSTEES OF COLUMBIA UNIVERSITY NEW YORK, NY
MAASTRICHT UNIVERSITY MAASTRICHT
UNIVERSITA DEGLI STUDI DI GENOVA GENOVA
46332/676ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.